What is the relationship between forced vital capacity (FVC) and heart failure?

FVC and Its Correlation with Heart Failure

Reduced forced vital capacity (FVC) is a robust independent predictor of heart failure risk, with each 10-unit decrease in percent-predicted FVC associated with a 21% increased risk of heart failure with preserved ejection fraction (HFpEF), even after adjusting for cardiovascular risk factors.

Strength of the Association

The relationship between FVC and heart failure is well-established across multiple large population studies:

• In the ARIC study of 3,854 elderly participants (mean age 75 years), lower percent-predicted FVC was independently associated with incident HFpEF (HR 1.21 per 10-unit decrease, 95% CI 1.04-1.41, p=0.013) but not with HFrEF 1

• A UK Biobank analysis of 406,424 individuals demonstrated that those with FVC <60% predicted had a hazard ratio of 1.98 (95% CI 1.76-2.22) for overall mortality and 2.26 (95% CI 1.94-2.63) for cardiovascular mortality over 12.5 years 2

• The Framingham Study found that among 818 subjects with coronary disease or left ventricular hypertrophy, those in the lowest FVC quartile had 1.8-2.3 times higher risk of developing cardiac failure compared to the highest quartile 3

Mechanisms Linking FVC to Heart Failure

The pathophysiological connections between reduced FVC and heart failure involve multiple pathways:

• Lower FVC associates with elevated NT-proBNP levels, higher pulmonary artery pressures, increased left ventricular mass, elevated left ventricular filling pressures, and higher inflammatory markers (high-sensitivity C-reactive protein) 1

• In elderly persons with hypertension or coronary disease, FVC reductions of 50-150 mL are observed, while congestive heart failure is associated with 200-300 mL decrements in FVC 4

• The relationship persists even in never-smokers and individuals with normal spirometry at baseline, suggesting mechanisms beyond smoking-related lung damage 2

Clinical Implications for Risk Stratification

FVC measurement provides valuable prognostic information across different clinical scenarios:

• In a 23-year follow-up study of 20,998 men, each 1 standard deviation lower FVC was associated with a 26% increased risk of heart failure hospitalization in non-smokers (HR 1.26,95% CI 1.13-1.42) and 22% in smokers (HR 1.22,95% CI 1.11-1.33) 5

• The association remained consistent in men with and without hypertension, above and below median age, and for heart failure events without previous myocardial infarction 5

• Importantly, the increased cardiovascular risk is evident even at FVC levels exceeding 80% predicted, challenging the notion that values above this threshold represent entirely normal lung function 2

Differential Impact on HFpEF vs HFrEF

The relationship between FVC and heart failure subtypes shows important distinctions:

• Lower FVC specifically predicts HFpEF development but not HFrEF, suggesting distinct pathophysiological mechanisms 1

• In contrast, reduced FEV1/FVC ratio (indicating obstruction) shows trends toward increased risk for both HFpEF (HR 1.31 per 10-point decrease) and HFrEF (HR 1.24 per 10-point decrease), though these did not reach statistical significance 1

• Rapid decline in both FEV1 and FVC together confers higher risk (HR 1.390 for heart failure, 95% CI 1.041-1.833) than decline in either parameter alone 6

Practical Application for Clinicians

FVC should be used as a risk stratification tool in patients with cardiovascular disease predisposition:

• In patients with coronary disease or left ventricular hypertrophy, FVC determination helps identify candidates for cardiac failure screening who need echocardiographic examination for ventricular dysfunction 3

• Substantial decrements in FVC should not be attributed solely to uncomplicated ischemic heart disease or hypertension; further cardiac evaluation is warranted 4

• Serial FVC measurements may help identify patients at accelerating cardiovascular risk, as rapid decline in FVC is associated with 39% increased risk of heart failure 6

Important Caveats

• The magnitude of FVC reduction associated with uncomplicated hypertension or ischemic heart disease is relatively small (40-150 mL) unless heart failure supervenes, when decrements reach 200-300 mL 4

• While FVC is a robust predictor, it should be interpreted alongside clinical context, as the relationship exists independently but does not establish causation 2, 1

• The prognostic value of FVC for heart failure risk extends across the entire spectrum of lung function, not just in those with overt pulmonary disease 2